Bianfei Shao

Chongqing Key Laboratory For Intelligent Oncology In Breast Cancer
Chongqing, 400030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

The tumor suppressor DACT3 sensitizes triple-negative breast cancer to apatinib by inhibiting the Wnt/β-catenin pathway.

The tumor suppressor DACT3 sensitizes triple-negative breast cancer to apatinib by inhibiting the Wnt/β-catenin pathway.

Journal: Translational oncology
Published: April 03, 2025

Multifaceted role of T-box transcription factor 4: From embryonic development to disease pathogenesis.

Multifaceted role of T-box transcription factor 4: From embryonic development to disease pathogenesis.

Journal: Genes & diseases
Published: February 04, 2025

A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1.

A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1.

Journal: Biomaterials
Published: December 11, 2024

Radiotherapy-immunomodulated nanoplatform triggers both hypoxic and normoxic tumor associated antigens generation for robust abscopal effect and sustained immune memory.

Radiotherapy-immunomodulated nanoplatform triggers both hypoxic and normoxic tumor associated antigens generation for robust abscopal effect and sustained immune memory.

Journal: Biomaterials
Published: October 13, 2024

NKAPL suppresses NSCLC progression by enhancing the protein stability of TRIM21 and further inhibiting the NF-κB signaling pathway.

NKAPL suppresses NSCLC progression by enhancing the protein stability of TRIM21 and further inhibiting the NF-κB signaling pathway.

Journal: Genes & diseases
Published: August 28, 2024

Role of ZNF334 in cervical cancer: implications for EMT reversal and tumor suppression.

Role of ZNF334 in cervical cancer: implications for EMT reversal and tumor suppression.

Journal: Medical oncology (Northwood, London, England)
Published: April 27, 2024

The novel DNA methylation marker FIBIN suppresses non-small cell lung cancer metastasis by negatively regulating ANXA2.

The novel DNA methylation marker FIBIN suppresses non-small cell lung cancer metastasis by negatively regulating ANXA2.

Journal: Cellular signalling
Published: January 21, 2024

Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

Journal: Clinical epigenetics
Published: March 10, 2022

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment.

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment.

Journal: Frontiers in oncology
Published: November 04, 2021

The Clinical Application of 3D-Printed Boluses in Superficial Tumor Radiotherapy.

The Clinical Application of 3D-Printed Boluses in Superficial Tumor Radiotherapy.

Journal: Frontiers in oncology
Published: April 22, 2021

ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

Journal: Clinical epigenetics
Published: August 17, 2019

TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.

TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.

Journal: Clinical epigenetics
Published: March 01, 2018
Showing 1-12 of 17

Last Updated: 09/26/2026